May 30, 2014 / 3:06 PM / 3 years ago

Shire considering bid for NPS Pharmaceuticals - FT

LONDON, May 30 (Reuters) - London-listed drugmaker Shire is considering a bid for New Jersey-based NPS Pharmaceuticals, FT Alphaville reported on Friday citing sources.

Shire has been working with advisers and held internal discussions about a potential cash offer for NPS, a rare disease specialist, valuing the business at just over $4 billion, the Financial Times blog said.

Shares in Nasdaq-listed NPS were trading 15.5 percent higher at 1500 GMT giving the company a market capitalisation of $2.92 billion. Shares in Shire were trading down 1.4 percent.

Reporting By Anjuli Davies, editing by Steve Slater

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below